{
  "retracted": false,
  "timestamp": 1455580800000,
  "updates": [
    {
      "timestamp": 1559236526141,
      "identifier": {
        "doi": "10.1007/s10549-016-3702-6"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-012-2079-4"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option"
}
